136 related articles for article (PubMed ID: 23188442)
1. Immunoexpression of Ki67 and cyclin D1 in oral squamous carcinomas.
Olimid DA; Simionescu CE; Mărgăritescu C; Florescu A
Rom J Morphol Embryol; 2012; 53(3 Suppl):795-8. PubMed ID: 23188442
[TBL] [Abstract][Full Text] [Related]
2. [Ki67, p53 and cyclin D1 in the squamous cell carcinoma of head and neck].
Golusiński W; Golusiński P; Stańczak J; Kłosin J
Otolaryngol Pol; 2004; 58(4):777-84. PubMed ID: 15603389
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
Angadi PV; Krishnapillai R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
[TBL] [Abstract][Full Text] [Related]
4. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis.
Kotelnikov VM; Coon JS; Mundle S; Kelanic S; LaFollette S; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Preisler HD
Clin Cancer Res; 1997 Jan; 3(1):95-101. PubMed ID: 9815543
[TBL] [Abstract][Full Text] [Related]
6. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis.
Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ
Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608
[TBL] [Abstract][Full Text] [Related]
7. Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma.
Saawarn S; Astekar M; Saawarn N; Dhakar N; Gomateshwar Sagari S
ScientificWorldJournal; 2012; 2012():978327. PubMed ID: 22629227
[TBL] [Abstract][Full Text] [Related]
8. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of tumor cyclin D1 expression in oral cancer.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Bravo M; Gil-Montoya JA
Arch Oral Biol; 2019 Mar; 99():177-182. PubMed ID: 30721793
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
Nazar M; Naz I; Mahmood MK; Hashmi SN
Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
[TBL] [Abstract][Full Text] [Related]
11. P53, p16 and Ki67 immunoexpression in oral squamous carcinomas.
Dragomir LP; Simionescu C; Mărgăritescu C; Stepan A; Dragomir IM; Popescu MR
Rom J Morphol Embryol; 2012; 53(1):89-93. PubMed ID: 22395505
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.
Kushner J; Bradley G; Young B; Jordan RC
J Oral Pathol Med; 1999 Feb; 28(2):77-81. PubMed ID: 9950254
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.
Tarle M; Raguž M; Muller D; Lukšić I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982894
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
16. Asymmetrical proliferative pattern loss linked to cyclin D1 overexpression in adjacent non-tumour epithelium in oral squamous cell carcinoma.
Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Lenouvel D; Gil-Montoya JA; Bravo M
Arch Oral Biol; 2019 Jan; 97():12-17. PubMed ID: 30321764
[TBL] [Abstract][Full Text] [Related]
17. Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression.
Stewart CJ; Crook ML
J Clin Pathol; 2014 Apr; 67(4):319-25. PubMed ID: 24218024
[TBL] [Abstract][Full Text] [Related]
18. Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.
Poi MJ; Knobloch TJ; Sears MT; Uhrig LK; Warner BM; Weghorst CM; Li J
Anticancer Res; 2014 Jul; 34(7):3285-92. PubMed ID: 24982332
[TBL] [Abstract][Full Text] [Related]
19. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
Wang L; Liu T; Nishioka M; Aguirre RL; Win SS; Okada N
Oral Oncol; 2006 Jul; 42(6):625-31. PubMed ID: 16483832
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
